Gaucher Disease Type 3 Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Gaucher Disease Type 3
Gaucher disease type 3 is a rare genetic disorder affecting the brain, bones, and other organs due to a deficiency in the GBA enzyme. Managing this lifelong condition often involves costly medications. TheDrugClub offers a simple solution, helping members save significantly on essential prescriptions, making treatment more accessible and affordable for individuals and families facing this challenge.
Gaucher disease type 3 is a progressive, inherited condition that falls under the umbrella of lysosomal storage disorders. It's caused by a mutation in the *GBA* gene, which leads to a deficiency in the enzyme glucocerebrosidase. This enzyme is crucial for breaking down a fatty substance called glucocerebroside. When the enzyme is deficient, glucocerebroside builds up in various organs, including the spleen, liver, bones, and, critically, the brain.
Unlike Gaucher type 1, type 3 includes neurological symptoms, which can vary widely in severity and onset. These may include seizures, coordination problems, eye movement disorders, and learning difficulties, alongside systemic issues like an enlarged spleen and liver, bone pain, and fatigue. It's a chronic condition requiring lifelong management.
While there is currently no cure for Gaucher disease type 3, treatments focus on managing symptoms, preventing complications, and slowing disease progression. The primary treatment approach is Enzyme Replacement Therapy (ERT), where the missing enzyme is administered intravenously. Common ERT medications include imiglucerase (Cerezyme), velaglucerase alfa (Vpriv), and taliglucerase alfa (Elelyso). Another option is Substrate Reduction Therapy (SRT), which works by reducing the amount of glucocerebroside the body produces. Oral medications like miglustat (Zavesca) and
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.